3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Tuberous Sclerosis
3
Seizures
3
Sturge-Weber Syndrome
2
Nausea
2
Vomiting
1
Parasomnias
1
Pain
1
Neoplasms
1
Marijuana Abuse
1
Dysgeusia
1
Drug Resistant Epilepsy
1
Cognitive Dysfunction
1
Chemotherapy-Induced Peripheral Neuropathy
1
Cancer Pain
1
Cachexia
1
Breast Neoplasms
1
Behavior
1
Arthralgia
1
Appetitive Behavior
1
Anxiety Disorders
1
Interventions
Therapeutics
9
Psychiatric Rehabilitation
9
Music Therapy
8
Cognitive Behavioral Therapy
7
Mindfulness
6
Surveys and Questionnaires
5
Counseling
5
Acupuncture Therapy
5
Standard of Care
4
Mindfulness-Based Stress Reduction
4
Methods
4
Imagery, Psychotherapy
4
Early Intervention, Educational
4
Autogenic Training
4
Art Therapy
4
Therapeutic Touch
3
Psychosocial Intervention
3
Psilocybin
3
Mindfulness-Based Cognitive Therapy
3
Massage
3
Hypnosis
3
Exercise
3
Control Groups
3
Aromatherapy
3
Acceptance and Commitment Therapy
3
Yoga
2
Touch
2
Observation
2
Niacin
2
Gabapentin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Anxiety Disorders
×
Cannabidiol
×
Clear all
NCT03948074
2025-09-10
CAFCARS
British Columbia Cancer Agency
Phase 2
Completed
91 enrolled